Coherent Market Insights published a business research report on Neonatal Ventilation and Nasal CPAP Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2022–2028. Neonatal Ventilation and Nasal CPAP Market with 150+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. The information is gathered based on modern floats and requests identified with the administrations and items.
Get Sample Report with Latest Covid19 Impact Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/4083
The Neonatal ventilation and nasal CPAP is a reliable form of CPAP because it has a higher probability of removing CO2 from the airway. The Neonatal ventilation and nasal CPAP relies on the electrical activity of the diaphragm to generate pressure and ventilation. It is positioned at the level of the crura of the diaphragm. The drawback of this device is that it may not work well in infants with frequent central apneas and hyperventilation.
Nasopharyngeal CPAP minimizes the risk of pleural effusion, which can be a serious complication of mechanical ventilation. Unlike other endotractaryngeal tubes, the Nasopharyngeal CPAP is easier to apply and can be applied to infants of any size. The technology is also more flexible and can be used on babies of any position.
According to data published by US National Library of Medicine, in 2014, respiratory distress is one of the most common reasons an infant is admitted to the neonatal intensive care unit, wherein, 29% of late preterm infants are admitted to the neonatal intensive care unit due to respiratory distress and Neonatal Respiratory Disease Syndrome NRDS accounted for 2.3% of all infant deaths in the U.S. in 2013
Global Neonatal Ventilation and Nasal CPAP Market- Impact of COVID-19 Analysis
The impact of COVID-19 on the global neonatal ventilation and nasal CPAP market has affected in a positive way. Scarcity of ventilators during this pandemic has been an important issue throughout the world. The governments of various countries have sanctioned loans for boosting the production and manufacturing of ventilators in health care sectors. Thus, there has been significant changes in healthcare infrastructure, as small cities and towns are incorporating modern facilities to encompass ventilator systems within their hospitals and nursing homes. All these factors are key drivers to boost application of intensive care ventilators in COVID-19 pandemic.
Global Neonatal Ventilation and Nasal CPAP Market- Drivers
Neonatal ventilation and nasal CPAP are majorly used to treat respiratory distress in neonates. There has been rise in number of research and development programs in the global neonatal ventilation and nasal CPAP market from last decade. For instance, in 2016, B&B Medical Technologies announced that the Bubbler 12.5 cm H2O Pressure Relief Manifold is available for immediate sale. The unit is for use in bubble CPAP systems and is a companion product to B&B’s popular Bubbler Water Seal CPAP Valve. The Pressure Relief Manifold is U.S. Food and Drug Administration (FDA) approved and carries the CE mark.
According to data published by US National Library of Medicine in 2014, around 1% of infants develop respiratory distress syndrome globally and in the U.S., 12% of babies were born prematurely having risk of respiratory distress and accounted for 2.3% of infant deaths due to respiratory distress syndrome in 2013. Such factors are projected to drive the global neonatal ventilation and nasal CPAP market growth over the forecast period.
Global Neonatal Ventilation and Nasal CPAP Market- Restraints
Discomfort of patients while using CPAP in nasal cavity and claustrophobia is is expected to hinder growth of neonatal ventilation and nasal CPAP market. Additionally, other restraints commonly observed are leaks, added death space, weight long trigger, probe cost, and invasive. In India, neonatal and nasal CPAP are out of pocket expense for most of the Indian population. For instance, according to India Mart, the cost of neonatal ventilator is approx. US$ 7,680 per unit in India. These factors are expected to restrain the global neonatal ventilation and nasal CPAP market growth over the forecast period.
Global Neonatal Ventilation and Nasal CPAP Market- Regional analysis
Regionally, the global neonatal ventilation and nasal CPAP market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. In North America, according to journal published by US National Library of Medicine in 2019, 12% of babies born in the U.S. were born prematurely–a higher rate than in other developed countries and Neonatal Respiratory Disease Syndrome (NRDS) accounted for 2.3% of all infant deaths in the U.S. in 2013. Product launches in the region are supporting growth of the market. For instance, in 2019, ResMed (US) launched AirFit N30i, its first top-of-head-connected nasal CPAP mask, across the U.S. Moreover, in 2018, Vyaire Medical acquired Acutronic and IMTmedical. Both the new acquisitions are based in Europe, with Acutronic split between Switzerland and Germany and IMTmedical based solely in Switzerland and Chicago. Key players in this region are Acutronic Medical Systems AG, Löwenstein Medical GmbH & Co. KG Niederlassung.
Moreover new product launches in the Asia Pacific region are augmenting growth of the market. For instance, in 2019, InnAccel Technologies Pvt Ltd. (India) launched SAANS: portable neonatal CPAP device for infants with respiratory distress syndrome. These factors are expected to support growth of the market over the forecast period.
Global Neonatal Ventilation and Nasal CPAP Market – Competitive Landscape
ResMed INC, Airon Corporation, GE Healthcare, Respironics, Inc, Acutronic Medical Systems AG, Lowenstein Medical GmbH & Co. KG Niederlassung, InnAccel Technologies Pvt Ltd, Phoenix Medical Systems Pvt. Ltd, PT. Fyrom International, BMC Medical Co., Ltd, Fisher & Paykel Healthcare Corporation Limited, Somnomed Ltd, Oventus Medical, Braebon Medical Corporation, and Drägerwerk AG.
- At Arab Health 2020, Dräger launched the new Evita V600 and V800 ventilators designed to support daily clinical tasks in the ICU. Both ventilators combine high performance ventilation with an aesthetic design, enabling quick and efficient operation from the first onset of lung protective ventilation until the integration of a patient care-centered intensive care workplace.
- In 2019, Silver Cross Hospital in New Lenox, US, planned to add a US$ 12.8 million neonatal intensive care unit
- In 2019, Vyaire Medical received the U.S. FDA clearance for Bellavista 1000e ventilator system. The Bellavista 1000e ventilator’s approval includes support for neonatal to adult patients, More than 8,200 Bellavista 1000e ventilators of Vyaire are in use across 92 countries outside the U.S.
Global Neonatal Ventilation and Nasal CPAP Market- Taxonomy
- By Product Type
- Invasive Ventilation
- Non-invasive Ventilation
- By End User
- Ambulatory Surgical Centers
- Home Care Setting
- By Mobility
- Intensive Care Ventilators
- Portable/Transportable Ventilators
- By Technology
- Mechanical Ventilators
- High Frequency Ventilators
- Volume Targeted Ventilators
- Hybrid Ventilators
- By Mode
- Pressure Mode Ventilation
- Combined Mode Ventilation
- Volume Mode Ventilation
- By Region
- North America
- Latin America
- Asia Pacific
- Middle East
Buy This Report With USD 2000 Flat OFF – https://www.coherentmarketinsights.com/promo/buynow/4083
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Global Neonatal Ventilation and Nasal CPAP Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: Neonatal Ventilation and Nasal CPAP Industry Impact
Chapter 2 Global Neonatal Ventilation and Nasal CPAP Competition by Types, Applications, and Top Regions and Countries
2.1 Global Neonatal Ventilation and Nasal CPAP (Volume and Value) by Type
2.3 Global Neonatal Ventilation and Nasal CPAP (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Neonatal Ventilation and Nasal CPAP Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Neonatal Ventilation and Nasal CPAP Market Analysis
Chapter 6 East Asia Neonatal Ventilation and Nasal CPAP Market Analysis
Chapter 7 Europe Neonatal Ventilation and Nasal CPAP Market Analysis
Chapter 8 South Asia Neonatal Ventilation and Nasal CPAP Market Analysis
Chapter 9 Southeast Asia Neonatal Ventilation and Nasal CPAP Market Analysis
Chapter 10 Middle East Neonatal Ventilation and Nasal CPAP Market Analysis
Chapter 11 Africa Neonatal Ventilation and Nasal CPAP Market Analysis
Chapter 12 Oceania Neonatal Ventilation and Nasal CPAP Market Analysis
Chapter 13 South America Neonatal Ventilation and Nasal CPAP Market Analysis
Chapter 14 Company Profiles and Key Figures in Neonatal Ventilation and Nasal CPAP Business
Chapter 15 Global Neonatal Ventilation and Nasal CPAP Market Forecast (2021-2027)
Chapter 16 Conclusions
Get PDF Brochure with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/4083
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027